Heron Therapeutics Files Definitive Proxy Statement
Ticker: HRTX · Form: DEFA14A · Filed: Apr 30, 2026 · CIK: 0000818033
| Field | Detail |
|---|---|
| Company | Heron Therapeutics, Inc. /De/ (HRTX) |
| Form Type | DEFA14A |
| Filed Date | Apr 30, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, shareholder-meeting
Related Tickers: HRTX
TL;DR
HRTX filed proxy docs, shareholder meeting incoming.
AI Summary
Heron Therapeutics, Inc. filed a Definitive Proxy Statement (DEFA14A) on April 30, 2026. This filing is related to soliciting proxies from shareholders for an upcoming meeting. The company's principal executive offices are located at 4242 Campus Point Court, Suite 200, San Diego, CA 92121.
Why It Matters
This filing is a standard procedural document for public companies, indicating that Heron Therapeutics is preparing for a shareholder meeting where important corporate decisions will be voted upon.
Risk Assessment
Risk Level: low — This filing is a routine proxy statement and does not contain new material information that would inherently increase risk.
Key Players & Entities
- HERON THERAPEUTICS, INC. (company) — Filer
- 0000818033 (company) — CIK number for Heron Therapeutics, Inc.
- 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 (company) — Mailing and Business Address
FAQ
What type of filing is this DEFA14A for Heron Therapeutics?
This DEFA14A filing is for Additional definitive proxy soliciting materials and Rule 14(a)(12) material.
When was this filing accepted by the SEC?
This filing was accepted on April 30, 2026.
What is Heron Therapeutics' CIK number?
Heron Therapeutics, Inc.'s CIK number is 0000818033.
Where are Heron Therapeutics' principal executive offices located?
Heron Therapeutics' principal executive offices are located at 4242 Campus Point Court, Suite 200, San Diego, CA 92121.
What is the SIC code associated with Heron Therapeutics?
The SIC code associated with Heron Therapeutics is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 30, 2026 regarding HERON THERAPEUTICS, INC. /DE/ (HRTX).